[go: up one dir, main page]

AU2002233994A1 - Secreted proteins - Google Patents

Secreted proteins

Info

Publication number
AU2002233994A1
AU2002233994A1 AU2002233994A AU3399402A AU2002233994A1 AU 2002233994 A1 AU2002233994 A1 AU 2002233994A1 AU 2002233994 A AU2002233994 A AU 2002233994A AU 3399402 A AU3399402 A AU 3399402A AU 2002233994 A1 AU2002233994 A1 AU 2002233994A1
Authority
AU
Australia
Prior art keywords
secreted proteins
secreted
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002233994A
Other languages
English (en)
Inventor
Olga Bandman
Mariah R. Baughn
Neil Burford
Li Ding
Brendan M. Duggan
Vicki S. Elliott
Ameena R. Gandhi
Kimberly J. Gietzen
April J. A. Hafalia
Cynthia D. Honchell
Craig H. Ison
Stephanie K. Kareht
Preeti G. Lal
Sally Lee
Dyung Aina M. Lu
Yan Lu
Madhusudan Sanjanwala
Anita Swarnakar
Y. Tom Tang
Kavitha Thangavelu
Michael Thornton
Bao Tran
Narinder K. Walia
Bridget A. Warren
Yuming Xu
Junming Yang
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002233994A1 publication Critical patent/AU2002233994A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L1/00—Arrangements for detecting or preventing errors in the information received
    • H04L1/12—Arrangements for detecting or preventing errors in the information received by using return channel
    • H04L1/16—Arrangements for detecting or preventing errors in the information received by using return channel in which the return channel carries supervisory signals, e.g. repetition request signals
    • H04L1/1607—Details of the supervisory signal
    • H04L1/1657—Implicit acknowledgement of correct or incorrect reception, e.g. with a moving window

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2002233994A 2000-11-08 2001-11-08 Secreted proteins Abandoned AU2002233994A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US24750500P 2000-11-08 2000-11-08
US60/247,505 2000-11-08
US24982400P 2000-11-16 2000-11-16
US24964200P 2000-11-16 2000-11-16
US60/249,642 2000-11-16
US60/249,824 2000-11-16
US25282400P 2000-11-21 2000-11-21
US60/252,824 2000-11-21
US25430500P 2000-12-08 2000-12-08
US60/254,305 2000-12-08
US25644800P 2000-12-18 2000-12-18
US60/256,448 2000-12-18
PCT/US2001/047420 WO2002038602A2 (fr) 2000-11-08 2001-11-08 Proteines secretees

Publications (1)

Publication Number Publication Date
AU2002233994A1 true AU2002233994A1 (en) 2002-05-21

Family

ID=27559348

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002233994A Abandoned AU2002233994A1 (en) 2000-11-08 2001-11-08 Secreted proteins

Country Status (5)

Country Link
US (1) US20040082508A1 (fr)
EP (1) EP1341812A2 (fr)
AU (1) AU2002233994A1 (fr)
CA (1) CA2428140A1 (fr)
WO (1) WO2002038602A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974684B2 (en) * 2001-08-08 2005-12-13 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US7176010B2 (en) * 2000-08-10 2007-02-13 Takeda Pharmaceutical Company Limited Isolated human protein having esterase activity and DNA encoding the same
AU2002248156A1 (en) * 2000-11-01 2003-01-08 Zymogenetics, Inc. Testis protein, zsig86
JPWO2002064771A1 (ja) * 2001-02-15 2004-06-17 持田製薬株式会社 活性化白血球に特異的な新規細胞接着分子
WO2005003161A2 (fr) * 2003-06-30 2005-01-13 Genova Ltd. Nouvelles proteines secretoires
AU2006204459B2 (en) 2005-01-05 2012-11-01 F-Star Therapeutics Limited Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
WO2006102072A2 (fr) * 2005-03-23 2006-09-28 The Trustees Of The University Of Pennsylvania Utilisation d'un polypeptide pa131 dans le traitement de l'atherosclerose
CA2822302A1 (fr) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Procedes pour alterer la differenciation osteoclaste
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
AT503889B1 (de) 2006-07-05 2011-12-15 Star Biotechnologische Forschungs Und Entwicklungsges M B H F Multivalente immunglobuline
JP5602625B2 (ja) 2007-06-26 2014-10-08 エフ−スター ビオテヒノロギッシェ フォルシュングス− ウント エントヴィッケルングスゲゼルシャフト ミット ベシュレンクテル ハフツング 結合物質のディスプレイ
HUE025262T2 (en) 2007-10-11 2016-02-29 Daiichi Sankyo Co Ltd Antibody targeting osteoclast-linked Siglec-15 protein
EP2113255A1 (fr) 2008-05-02 2009-11-04 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Immunoglobuline cytotoxique
CN106317224B (zh) 2009-04-09 2020-05-12 第一三共株式会社 抗-Siglec-15抗体
KR20130066682A (ko) 2010-10-05 2013-06-20 다이이찌 산쿄 가부시키가이샤 항체 표적 파골세포－관련 단백질 ｓｉｇｌｅｃ－１５
KR20150003170A (ko) 2012-03-30 2015-01-08 다이이찌 산쿄 가부시키가이샤 ＣＤＲ 개변 항 Ｓｉｇｌｅｃ-15 항체
WO2014012165A1 (fr) 2012-07-19 2014-01-23 Alethia Biotherapeutics Inc. Anticorps anti-siglec-15
WO2025106716A2 (fr) * 2023-11-14 2025-05-22 Alphina Therapeutics, Inc. Anticorps anti-naprt et procédés d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2328489A1 (fr) * 1998-05-18 1999-11-25 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
CA2339418A1 (fr) * 1998-08-10 2000-02-24 Genetics Institute, Inc. Proteines humaines connexes a la chordine et polynucleotides les codant
CA2339047A1 (fr) * 1998-08-14 2000-02-24 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
GB0012186D0 (en) * 2000-05-20 2000-07-12 Univ Leeds Treatment of cancer and neurological diseases

Also Published As

Publication number Publication date
CA2428140A1 (fr) 2002-05-16
US20040082508A1 (en) 2004-04-29
WO2002038602A2 (fr) 2002-05-16
EP1341812A2 (fr) 2003-09-10
WO2002038602A3 (fr) 2003-06-26

Similar Documents

Publication Publication Date Title
AU2001271683A1 (en) Novel secreted proteins
AU2001280471A1 (en) Novel secreted proteins and their uses
AU2002233994A1 (en) Secreted proteins
AU2002361452A1 (en) Secreted proteins
AU2001270045A1 (en) Secreted proteins
AU2002353227A1 (en) Secreted proteins
AU2001227833A1 (en) 71 human secreted proteins
AU2002232596A1 (en) Secreted human proteins
AU2002342010A1 (en) Secreted proteins
AU2001255320A1 (en) Secreted proteins
AU2001237957A1 (en) 17 human secreted proteins
AU2002354803A1 (en) Secreted proteins
AU2002211220A1 (en) Secreted proteins and their uses
AU2002252700A1 (en) Secreted proteins
AU2002255733A1 (en) Secreted proteins
AU2001294719A1 (en) Secreted human proteins
AU2001290551A1 (en) Secreted proteins and their uses
AU2001229366A1 (en) Secreted proteins
AU2002236440A1 (en) Novel secreted proteins and their uses
AU2002327533A1 (en) Secreted proteins
AU2002258657A1 (en) Secreted proteins
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001229507A1 (en) 21 human secreted proteins
AU2390800A (en) Secreted proteins